Frequent and histological type-specific inactivation of 14-3-3sigma in human lung cancers.
about
Targeted proteomic analysis of 14-3-3 sigma, a p53 effector commonly silenced in cancerCpG island promoter methylation and silencing of 14-3-3sigma gene expression in LNCaP and Tramp-C1 prostate cancer cell lines is associated with methyl-CpG-binding protein MBD2Genetic alteration and gene expression modulation during cancer progressionExploration of global gene expression patterns in pancreatic adenocarcinoma using cDNA microarraysImmunohistochemical demonstration of 14-3-3 sigma protein in normal human tissues and lung cancers, and the preponderance of its strong expression in epithelial cells of squamous cell lineage14-3-3 proteins--an updateThe role of epigenetic inactivation of 14-3-3sigma in human cancer14-3-3 isoforms bind directly exon B of the 5'-UTR of human surfactant protein A2 mRNA14-3-3σ Gene Loss Leads to Activation of the Epithelial to Mesenchymal Transition Due to the Stabilization of c-Jun ProteinLung Cancer: Are we up to the Challenge?Identification of differentially expressed genes in immortalized human bronchial epithelial cell line as a model for in vitro study of lung carcinogenesis.Proteomic identification of 14-3-3 sigma as a common component of the androgen receptor and the epidermal growth factor receptor signaling pathways of the human prostate epithelial cell line M12.Downregulation of RUNX3 and TES by hypermethylation in glioblastoma.Aberrant overexpression of an epithelial marker, 14-3-3sigma, in a subset of hematological malignanciesRole of 14-3-3σ in poor prognosis and in radiation and drug resistance of human pancreatic cancers.Lung cancer: a modified epigenome.Loss of cytoplasmic CDK1 predicts poor survival in human lung cancer and confers chemotherapeutic resistanceAberrant upregulation of 14-3-3ơ expression serves as an inferior prognostic biomarker for gastric cancer.Identification of isocitrate dehydrogenase 1 as a potential diagnostic and prognostic biomarker for non-small cell lung cancer by proteomic analysis.Chromosome instability in human lung cancers: possible underlying mechanisms and potential consequences in the pathogenesis.Identification of novel biomarker candidates for the immunohistochemical diagnosis of cholangiocellular carcinoma.The role and regulatory mechanism of 14-3-3 sigma in human breast cancer.Increasing 14-3-3 sigma expression with declining estrogen receptor alpha and estrogen-responsive finger protein expression defines malignant progression of endometrial carcinoma.14-3-3ζ as a prognostic marker and therapeutic target for cancerEpigenetic regulation of the cell type-specific gene 14-3-3sigma.Genetic alterations of multiple tumor suppressors and oncogenes in the carcinogenesis and progression of lung cancer.Proteomic analysis of differentially expressed proteins in vitamin C-treated AGS cells.Downregulation of 14-3-3σ correlates with multistage carcinogenesis and poor prognosis of esophageal squamous cell carcinomaHigher expression levels of 14-3-3sigma in ductal carcinoma in situ of the breast predict poorer outcome.14-3-3 proteins as potential therapeutic targets.DNA methylation profiles delineate epigenetic heterogeneity in seminoma and non-seminomaCTRP3 Stimulates Proliferation and Anti-Apoptosis of Prostate Cells through PKC Signaling Pathways.Bisdemethoxycurcumin induces DNA damage and inhibits DNA repair associated protein expressions in NCI-H460 human lung cancer cells.Dynamic interactions between 14-3-3 proteins and phosphoproteins regulate diverse cellular processes.Throwing new light on lung cancer pathogenesis: updates on three recent topics.Genome-scale analysis of DNA methylation in lung adenocarcinoma and integration with mRNA expression.Decreased expression of 14-3-3 σ, an early event of malignant transformation of respiratory epithelium, also facilitates progression of squamous cell lung cancer.The 14-3-3σ/GSK3β/β-catenin/ZEB1 regulatory loop modulates chemo-sensitivity in human tongue cancer14-3-3 proteins: do they have a role in human cancer?Study of promoter methylation pattern of 14-3-3 sigma gene in normal and cancerous tissue of breast: A potential biomarker for detection of breast cancer in patients.
P2860
Q24298526-139266EC-CAA1-43CE-AE50-C89DD27E6D80Q24684224-CCA2E277-D502-4EF4-95F9-0210B37D5DE9Q24798750-EC5928B1-E1F6-41AB-AC8B-4F58531EE8CAQ28185685-97AC196C-8506-4430-B8CE-933F98F4CBB1Q28208788-80F6731C-0D98-485E-A91B-5C21AA9B172EQ28247242-0DD06C34-1154-4B8C-B64C-A5097DA888FAQ28247253-63B485CD-5037-4EA4-8CB8-3AA64BBB83D1Q28262330-D2AA2489-9A9E-48AF-9DCF-258A2D775BA8Q28385396-F967E015-EEF4-49A3-88E6-289787D327D1Q28386607-89094C4D-36CC-402C-AAEE-080CD7795374Q30758961-D9BD6CAD-C2E9-45E1-B6AD-9B33E77740C3Q33205584-2D9391F1-9698-497A-8579-287BC4217BFCQ33253913-AAD2B2AA-F5D6-4535-A2BA-A586E9E4C483Q33307070-85DA0EEF-7E63-4A65-A102-CEED1D8C7D49Q33735346-F2E87865-0145-439B-ABE7-99FE96BAE0CBQ33781123-11AD56EE-62ED-4713-8693-7B45A697C04AQ34009646-FC9D8949-FC35-47B4-93F0-815E104228D9Q34024640-AADC91D5-0746-4CA6-ACE3-FFD5BAA84D23Q34069325-D29C0EA3-AD92-4FF9-A843-5C75B145BE70Q34152941-32E4BAAE-2A93-43DD-8E1F-C16030E1BA84Q34303381-F26743F3-C953-4BA8-8E1B-4D76210319A0Q34340581-E2FD59CF-E72A-470D-8B9A-03EE73B9DCD8Q34465387-CE165338-6E07-4575-A42E-C0B7912F62E2Q34473399-E1CB5508-7DE2-4631-8202-391AB684EE0DQ34769713-9903C19A-81E0-450B-8520-1AD9547CD1B8Q34963574-7C2D74AA-6A75-4FA7-90C7-9C327CA2A7EBQ34997759-2417EDE1-B539-416A-B39E-AC45B82A591DQ35152011-46735F51-7C2C-420A-B605-24E0CBDB1FDEQ35207321-A8AD92A3-2330-4352-BAD0-5EF21F7A4A71Q35510924-8F90B3D0-CC90-4DA9-BEE1-323D0600D11EQ35682021-627B5B36-1FF8-43F2-B03A-491456B0C60DQ35720297-038BA929-8A25-41F1-BF17-397C46146A96Q35762335-32FBF835-F6F0-4AFF-B45D-A1B3D7867C0BQ35787179-90461C71-40E1-4769-9214-16B15EC58B83Q36050719-4120038C-55D7-4AFC-8C14-98BC85C902FBQ36093867-BE5B8588-74C5-4096-9B7C-620E59B82484Q36247870-FCBD5A09-76EB-4E98-8FA7-5F14145A0903Q36299623-28BEEF8D-037C-49C6-9EAE-66206F9A887BQ36429571-6A623DD5-D0D5-4707-9547-54242EF4DDD7Q36529431-4B3B9656-3E34-4072-B63F-4FEF2F9B28DE
P2860
Frequent and histological type-specific inactivation of 14-3-3sigma in human lung cancers.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh
2002年學術文章
@zh-hant
name
Frequent and histological type ...... -3sigma in human lung cancers.
@en
Frequent and histological type ...... -3sigma in human lung cancers.
@nl
type
label
Frequent and histological type ...... -3sigma in human lung cancers.
@en
Frequent and histological type ...... -3sigma in human lung cancers.
@nl
prefLabel
Frequent and histological type ...... -3sigma in human lung cancers.
@en
Frequent and histological type ...... -3sigma in human lung cancers.
@nl
P2093
P356
P1433
P1476
Frequent and histological type ...... -3sigma in human lung cancers.
@en
P2093
Ekmel Tezel
Hirotaka Osada
Hiroyuki Konishi
Minoru Takada
Takashi Takahashi
Taku Nakagawa
Tomoko Harano
Yoshio Tatematsu
P2888
P304
P356
10.1038/SJ.ONC.1205303
P407
P577
2002-04-01T00:00:00Z
P5875
P6179
1010456221